Aromatase inhibitors for breast cancer
Aromatase inhibitors for breast cancer This is a major handicap to the development of novel nonsteroidal AIs with superior clinical properties. Computational methodologies such as docking of LTZ and ANZ into the AROM active site cavity, molecular dynamics simulations, and energy minimization are